Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SERPINI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TOMM20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCND1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HGF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC33A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPL35A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMSAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPRD1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM39A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTDH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHTF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SS18L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRMT10C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP3CA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAT9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on